Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by nemo3on Jan 22, 2019 1:32am

87 Views

Post# 29262954

RE:RE:RE:Phase 2 trial

One thing that comes to mind too is how long it will take to get FDA approval. I guess if ph2 in Canada shows great results, FDA could fast track the trial in the US or perhaps approve TLTs treatment outright. I looked on FDAs site tonight and I don't see TLT in there at all. Patience pstience patience is what one needs with TLT.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments